Tivic Health Systems, Inc. (TIVC)
NASDAQ: TIVC · Real-Time Price · USD
0.459
-0.051 (-9.92%)
At close: Feb 21, 2025, 4:00 PM
0.450
-0.009 (-2.05%)
After-hours: Feb 21, 2025, 7:59 PM EST
Tivic Health Systems Employees
Tivic Health Systems had 9 employees as of December 31, 2023. The number of employees decreased by 7 or -43.75% compared to the previous year.
Employees
9
Change (1Y)
-7
Growth (1Y)
-43.75%
Revenue / Employee
$106,333
Profits / Employee
-$713,444
Market Cap
4.35M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 9 | -7 | -43.75% |
| Dec 31, 2022 | 16 | 9 | 128.57% |
| Dec 31, 2021 | 7 | -1 | -12.50% |
| Dec 31, 2020 | 8 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
TIVC News
- 10 days ago - Tivic Health Acquires Exclusive Worldwide Rights to Phase III TLR5 Agonist from Statera Biopharma - Business Wire
- 2 months ago - CEO Letter to Shareholders Issued by Tivic Health - Business Wire
- 3 months ago - Tivic Reports Third Quarter 2024 Financial Results and Provides Business Update - Business Wire
- 3 months ago - Tivic Health Systems, Inc. (TIVC) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Enrollment Complete in Tivic Health Optimization Study for its Non-Invasive Vagus Nerve Stimulation Device - Business Wire
- 3 months ago - Tivic Health Validates European Patents in Great Britain, Germany, and France - Business Wire
- 3 months ago - Tivic Health Systems, Inc. to Report Third Quarter 2024 Financial Results on November 14 - Business Wire
- 4 months ago - First Subject Enrolled in Tivic Health's Optimization Study for its Non-Invasive Vagus Nerve Stimulation Device - Business Wire